Analysts often have a good sense about the development of stocks due to their intensive research related to the company.
Not all analysts predict the correct economic development but they do a very good basic desk research and they have conversations with the management teams of the company, so not many people a as good informed as analysts.
Today I've listed all stocks with more than 10 years of consecutive dividend growth (Dividend Achievers) and a strong buy rating. Only nine companies have received the highest buy rating by analysts. Six of them are listed on the technology stock exchange NASDAQ.
Only four firms have a market capitalization over one billion US-Dollar. Keep in mind that those stocks also contain a higher risk for invvestors.
The only 9 Dividend Achievers with a strong buy rating are....
Vector Group (NYSE:VGR) has a market capitalization of $2.08 billion. The company employs 989 people, generates revenue of $1,056.20 million and has a net income of $38.69 million. Vector Group’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $212.77 million. The EBITDA margin is 20.15 percent (the operating margin is 13.16 percent and the net profit margin 3.66 percent).
Financial Analysis: The total debt represents 54.94 percent of Vector Group’s assets and the total debt in relation to the equity amounts to percent. Due to the financial situation, a return on equity of percent was realized by Vector Group. Twelve trailing months earnings per share reached a value of $0.44. Last fiscal year, Vector Group paid $1.54 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 47.03, the P/S ratio is 1.97 and the P/B ratio is finally . The dividend yield amounts to 7.67 percent and the beta ratio has a value of 0.27.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_usHaWwf5dvP7FRoVXALJ_P3qR821vGo2XHOwsnqcGv7M77eaOZFe0VajHuURRxyaytptfkHnlTLO1442yq0kKaYeb3Irai5fmobjSUbxVN8scu49p7xbARrjjgP5Ehw2ZBpyDKFgJ4E7L3tl2dyKfpAn0gkwpwz7I=s0-d) |
Long-Term Stock Price Chart Of Vector Group (VGR) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sPx3ZvcA-iktN5Mhi7KY708vHSr_SSIgi0XYkh5o9OYsbnf9V5dT1ANtdqfSCnfD60aODw60ZRWxmmGWp7DnlhRXulPgTW1rA7-vYEe5muII4WGe6HTXM0ufWLAnNQknpLrjEZ_ttwRxmEVHPDs-A5HFe7vCoJrEdtH4XSSArN1lYyZAqMqdP4wqeybOyQeo8mqeOZ-mIE4hgSBcswu9BGbi3ZItqmaWQtaPWl_utxn4jui0yiFro_9J0fEpKMf0tlqBlEPsk44Phgnx8NYjYy9gyj5NQCXk12TIKlAHkPzIJtHYZrDcJ1L0uZxc-XMjsLZK2yRN1YeaQOkGBCcg=s0-d) |
Long-Term Dividend Payment History of Vector Group (VGR) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uv8Owg5jTE3cdi7wH6VLCH_gCsZCuxKWVZzh8mfJFT1FjP8sUoufn3sDad2jJVgyrtlpxmOSCs9ECSCIO_gNSWVv1j1VE3vc-l06kgu-XCx_fMg2llOCsbqDbigLTk4LpQGqj-USkcTkXpVrHVe7b2ct0py6jkiTvD3d-thBfpoR3WvUurN5QTTYy3AXpyRXGHnpTUPegqRdutfOXOiwELUQweg7Y_l9R11-ZFRcPApYrIeALLyG8xuzEa5gPMs_eXtSQb81u4pgWmGssRwe2DJEsemcrDU_DusRj41qH9RrBfEHyffH8Ru-FGegRmGTi_AIpAFoiV0ioqDbjk_o_ixJJCpttRgj-eIjRAKUDW3cGsfvD-uG6g2Qd4TGcXGEW2SUB3LBkdO5OqS6OER6Q0UuI1WOcL9L5EIrDfdYlAX-E12K2xj8ydYPnrvxXu27GNGOkfCPSMdSzzZ4W7vtwcN7fi4gIbUQvnwBAJx2EjmXz_f44fUhyohtadQG85aCcb0BIWpxUdvYl0tYw=s0-d) |
Long-Term Dividend Yield History of Vector Group (VGR) |
BHP Billiton (NYSE:BBL) has a market capitalization of $71.03 billion. The company employs 49,496 people, generates revenue of $65,953.00 million and has a net income of $12,820.00 million. BHP Billiton’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $28,819.00 million. The EBITDA margin is 43.70 percent (the operating margin is 31.84 percent and the net profit margin 19.44 percent).
Financial Analysis: The total debt represents 23.84 percent of BHP Billiton’s assets and the total debt in relation to the equity amounts to 46.96 percent. Due to the financial situation, a return on equity of 16.44 percent was realized by BHP Billiton. Twelve trailing months earnings per share reached a value of $5.58. Last fiscal year, BHP Billiton paid $2.32 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.06, the P/S ratio is 2.79 and the P/B ratio is finally 1.01. The dividend yield amounts to 3.51 percent and the beta ratio has a value of 1.70.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vUevDB70amIOE6bpZoDSO30xZsFi5ju1x04KpA29TtAQSGZnoUyDplYJOkzXIAs57-jk9U0dU7qV98p-QglxcKjUHbxIilFh23WQZNc2wA-aTsRAw7iLjmOn0BwNsRxyjv_UA_7ple5SeZawYXAN3blFWFm6OYtw=s0-d) |
Long-Term Stock Price Chart Of BHP Billiton (BBL) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sWlCQKfqA9UMGgaPC75onagxY2RYYIVxPB7zFgSOHnOjkH3q2z0vWTq6di0p2-TplJj55qQy7uOxiomAX672QPo0nwjuGthCSLMycWswPahfTKydjphoKMdQ4RTYFF-XcTeDeVaoMfABEoI6Z6ZiZyZBiM62OzPL3fOSgMCAnDu32Umn8F8bfajs5npD8sKhe7HdM00IngxvXUzfetUY4HTWHxE58-4I_4OonyTn_oOakz96ozx6ESJ-6e0-zzWZx1MDznFQ5wdidECvd8qeZwnE9RGoeeZ7D0DrlCHI2GQ8KXZCPZYQ50UhgABZMEJmBvIwK12c3HLjEsNydqvA=s0-d) |
Long-Term Dividend Payment History of BHP Billiton (BBL) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vXwU87y-7IW50GrOjiHbP4vkXLS7w2FMeEWpkkc5WeMSio0dOcgEzUTVfuwMSpOFumhTE2f_N3E1VFI4LFaKf_EGXT0T4_A6LmNIDjNOt437SIskIO6oPIZfO9Da5CAqsmGPYbiPeCNRc7eD2jbvEXEEw6GiVJaifHqIKAMY5kWt-RPDOgmWjygm7rpMKJevKXCq7pbS95785I1FMghAM7yKYK0sjG4Bwli72ha8noRVQ155ltOEkT-xvuNQNdsK6UNVTsyG6EHrBljSgAqzWE4DU_nk_MqjH-t4-CEM34malKCYhuyzeCini1N52PYvZuV_LqvUJel5KTYbiZCw_KxKDg9-ZIVETs5CxTgjiYYZd7uVt1a18MclPgQABU9yfC4r-h5vgDlTaWckhnIaHWBH1_X_ITq2EFBwEOFekmYbBzMPOIGnoCcPtR1ZT45Vt6d837wwwvFgmA82yZWWd89jUFCZn37dG5BwVnktKx07BMnGd2QPwJEanBP5Db9t_AaM89tAq-ym0aRou3=s0-d) |
Long-Term Dividend Yield History of BHP Billiton (BBL) |
Span-America Medical Systems (NASDAQ:SPAN) has a market capitalization of $58.09 million. The company employs 275 people, generates revenue of $73.83 million and has a net income of $5.07 million. Span-America Medical Systems’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8.58 million. The EBITDA margin is 11.62 percent (the operating margin is 9.88 percent and the net profit margin 6.86 percent).
Financial Analysis: The total debt represents 0.00 percent of Span-America Medical Systems’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 16.84 percent was realized by Span-America Medical Systems. Twelve trailing months earnings per share reached a value of $1.34. Last fiscal year, Span-America Medical Systems paid $0.38 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.60, the P/S ratio is 0.79 and the P/B ratio is finally 1.91. The dividend yield amounts to 2.85 percent and the beta ratio has a value of 0.46.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDkVo4_T2INWujEsWrj-J6TWFRn0laIgT8EmNsPavjF6OHvjnx-WVoi6U0KacsHLqu6voU5imXRmTkK2SKBZOtWbOobaO9-hVI_MepiSIRZwpE7QmRjFVbmGdNR4-yi9B1PxgvT_96GnGdZkZdrvNqKN--S46VkYEu=s0-d) |
Long-Term Stock Price Chart Of Span-America Medical Systems (SPAN) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_t6JoYKGkciEbmwbn-ehzqtycnsEP3-GKKo6SJ3lFpNaXjosa_kK_rLFotseQNWalqXiShVcErLfjV-NNZNn_urCscN5d38HrPozEEBiN-8Ua4mglgX4OqpYnILfja-yexHf_VzEPOBDA32NaPsgCkktJmkbuDa8WQZ2kr8obD7Zcnz4k7IEgwIN50FHYq0lq2tuyvKFVp2Da-FLzB1nH6gsdPMuppIJPw6NejYDinnuJo9-lckzICoANg9X2KaWyftKPKyIJZovHUtiJsE5Z8m69iDgRpoHtNzJQwmyDC6mMOenSdRK17ftnCEV017uXOMSGuFYsdthZ_BmKKv3Cos=s0-d) |
Long-Term Dividend Payment History of Span-America Medical Systems (SPAN) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sEasBkuLA6yVpkmM_B2fQ018SzSTgSEZxXcyejinLtuqBpJ4CnDOdNTwrYlT0RnU_hU9x1omFvahAtUTGYsIuazOeV9MoDHnjbbfKoMWae2_x84NQlCV22bbTuFgB0smIwFkUVIZiKpjfI4pKoP3nUGGsFjnxEr70ivaPjqh1pIuApycdBvTbP5LN8z9MozvJYC45fEfwjfrP52nBGUKkrtbcyt35_r1C0nIWxTg80gKb-QrdZiQM7vDhqOmT0AUU9tZA5DYEB-S0EaGlUFYa1UGogUI_t5r4rcb5FXsuxBwaUBMN7hLl9AQYKlBCMjtPtJVt97McVxwuLMwFZSzxdv29zgLrAFPlNaSEn5AHI1gF3qHAGSLgawLbkMhYyrX7PgK53FJg6S4vY3FFInn086zhUnT38s7Ezu1ep7TCWY5MOO1qK371DqIxrz6KlUUsgVdEqLYsAIh44V2nVdkkK80DPj9JosfrYamr13qaIh-Au6DKTesmpbGR3koLanryvdGjGSaI-Mrf2tSuSiOeY=s0-d) |
Long-Term Dividend Yield History of Span-America Medical Systems (SPAN) |
Eagle Bancorp Montana (NASDAQ:EBMT) has a market capitalization of $42.32 million. The company employs 185 people, generates revenue of $14.80 million and has a net income of $1.97 million. Eagle Bancorp Montana’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.34 million. The EBITDA margin is 28.03 percent (the operating margin is 5.85 percent and the net profit margin 8.73 percent).
Financial Analysis: The total debt represents 1.01 percent of Eagle Bancorp Montana’s assets and the total debt in relation to the equity amounts to 10.47 percent. Due to the financial situation, a return on equity of 3.84 percent was realized by Eagle Bancorp Montana. Twelve trailing months earnings per share reached a value of $0.49. Last fiscal year, Eagle Bancorp Montana paid $0.29 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 22.15, the P/S ratio is 1.87 and the P/B ratio is finally 0.86. The dividend yield amounts to 2.69 percent and the beta ratio has a value of 0.33.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v8jvhYhzS7dtu16nnW1MyvgeP3-Z_JByzaFKg9ZcLn6T4oHpzO5-mqQU2EBUFLfzerpA5d9JJmaHWfAXV0J0m_KvT3p7a1ykcZwRRk4m4BCzkOM91v3HnOTHFTjc1iQqRZKhrPn9j0H2t-uNW1wl7YJaZ8zcsvV7o=s0-d) |
Long-Term Stock Price Chart Of Eagle Bancorp Montana (EBMT) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vH5sBbpHq7BM_Bos6L8Fy_nYUPZO-8vPVKlnGEKQBEfsZpqkRHZqDNfP33sgXkyojimYV0uqWDwskF3PXMRH6OR8Vbp_hEOusrhdc2Snxk5jRzuQ5Eru48ioEivXLfS_Sx9DTc6cL5xhKIcB6p2cCzsL4qwEzl2hSWtb7YrZ1Hx9r9zpE4X4ynofaGmXhh_g1n7pP40MEbv9YCYjeoumQXl6yM1gn_f0YajPrLzYZO3yPaEYYylN5kbYeFxCob1V4bD9_P4yLYP29BB7WWEWcPuwMNnRUBmCL37fRYI8t6BPBddnFr393e22mEJbKMCmJXHLNR6_uQGVbyHzhI2XXB=s0-d) |
Long-Term Dividend Payment History of Eagle Bancorp Montana (EBMT) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sZUicwElU5FVM10BUD_3t-MDmpUKpkWBhGmMAagRoncVTeaX-xYl0WRnxupPMqegIA_s-OO20augcqUIeDPJqzwvDMXvH8pFCUqBU7z7UGzw_wJ27TWdUr9v9VLXPHKHSriHSaxrS2XjfxyBIM6c398l88zm1tpB-sNK4LYHFEOYDVcp9dn2EE1tUY_myENyVZFVwVv0y_qUpmI8GlZPfKO96QZCaRqv1p6QYlDGnCBUG_sb0izSlbxmw9IKfqJXppePJEiGQM8AfiSgtWlOTVqz4wuxuyc-SB8kt9kcr4350tS1kmguAhbOgTio6bPD_LombMICO2979QtHNoN84Widaim9jFbLPVsrb83yLdsfT4R_I0rTf_vTC07ePAlGZ_3tgK96f3h26IkVkR37kUE8evkzq9r9NbmkoE6VMOqN7vkuWRQdAmabcujfkIH53jHS6ZOzn6qp9sBQ_2jI3YF8gYNb2H3b_JuDzhtA536w-7177CFT2FhW8Zr62HpdwliklBFoc0uQXyl_OuOWjG=s0-d) |
Long-Term Dividend Yield History of Eagle Bancorp Montana (EBMT) |
Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $186.14 million. The company employs 177 people, generates revenue of $40.49 million and has a net income of $11.41 million. Utah Medical Products’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $18.02 million. The EBITDA margin is 44.51 percent (the operating margin is 36.62 percent and the net profit margin 28.17 percent).
Financial Analysis: The total debt represents 11.30 percent of Utah Medical Products’s assets and the total debt in relation to the equity amounts to 15.05 percent. Due to the financial situation, a return on equity of 20.45 percent was realized by Utah Medical Products. Twelve trailing months earnings per share reached a value of $3.01. Last fiscal year, Utah Medical Products paid $0.98 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 16.46, the P/S ratio is 4.60 and the P/B ratio is finally 3.06. The dividend yield amounts to 2.02 percent and the beta ratio has a value of 0.29.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sVw-1hqw7UeEZbtz70kgFcV9tbt4OH_ma8iCs9JsWbKvhkqdLm9Arb3sq3tdXyJofI2I8nK_OCXz9k7pXuekiYe9P5X_k9uuCKTmVjZCMJzd-Mr7dtIpX3uCjYEmJ9qr3wiNBBtowNXEsTUVghQT42SG6FsHf2QJ4=s0-d) |
Long-Term Stock Price Chart Of Utah Medical Products (UTMD) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_s_DETG9FPnVnKsUiPSB6zRSV9ZGZW6Sssk6HgSLVR4HSgncz2jXrrmxSjfOD9xo3LyKRp70sn0PwmFXCM1s9RWsHCCkfAK7Rtu5v_ROos3C2W6OIWfgYx3R0SofsJcbr82pejkspaB-hsX35e49E7Hk2NhTw1ygenLH3F86zWhiJ_kwKQDOnj4-LJafdAXpOKjNb1RSvS_DpmuhHg4iLO06WrRvQPK8TpUmXyhgEzVg5cKXd2eS4lS6EpkZr61sVbhNURh4xy3RsFAa2vfzqFrKc2xNAeOGSCRPet1xjwHhxoQV0iU0314aMN3iavq0aOWP0sExJn3hZwmGf5Di1c=s0-d) |
Long-Term Dividend Payment History of Utah Medical Products (UTMD) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tBoPXxrckHQVt9tZZoV75t3XVA6cYF2tdo5q0t7XDDvwEC8djxJCC7vTXLtvv8t_awbYUKWfus1lgi9ecyWUeImL2i1Pa1_26-s11AcQPlv5OI2KnJnR6NyEZYn82NhsDFQwqWwDvBLl3rF8ouWReBLx7Ba97mW0BdXnrn7aM8Ttdno_-YsoMQRuqPjucdJO3IrD8DodDsl3kBL9VxJuYeBA5IETB3zPgKYsGQWrvrxLhai_VAC68o5lObF2nj9GHAtZG4JXuH_tDUJK4-k3TV1eWmF6Na-aAi81pC8MwOo0wsxc2GpVvJGZHlv7R5__vToPpFDF95OlEX7NGLeZBsKGlakJ6bw5Oe5w8vBcsT-0u2ezAJMObbHsN-Y_CezJF8_-jjyDX60ZT9DvyHd1Ell3Rwy-DLDBalk1CdPQ6gVCoXiZLNMB9_8cta6th7X0Xfgw5FZ2IpHxbzQQpWo1F8Uka879r5zS_ynWQjDYXDSjnT3WXJoxmNilv5GJxVFC9lhQoBQ2E-Rox5Byu8nyc=s0-d) |
Long-Term Dividend Yield History of Utah Medical Products (UTMD) |
Acme United (NYSEMKT:ACU) has a market capitalization of $54.35 million. The company employs 180 people, generates revenue of $89.58 million and has a net income of $4.00 million. Acme United’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $7.08 million. The EBITDA margin is 7.91 percent (the operating margin is 6.56 percent and the net profit margin 4.47 percent).
Financial Analysis: The total debt represents 33.65 percent of Acme United’s assets and the total debt in relation to the equity amounts to 65.45 percent. Due to the financial situation, a return on equity of 12.15 percent was realized by Acme United. Twelve trailing months earnings per share reached a value of $1.23. Last fiscal year, Acme United paid $0.31 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 13.76, the P/S ratio is 0.61 and the P/B ratio is finally 1.55. The dividend yield amounts to 1.89 percent and the beta ratio has a value of 0.40.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sYK21hI8YAM8qFV2__j6TwGE-ImeEQ0LqECjwGeZ9KGtUszpuH2P5pC6KtxuIGZSmlDdqn4VW2Paz97LENat7wsmCCfFoiSsoru7zoDEvJ23mdQ6-lH_CjsXrZjoEK0HxBJIEodk1EuYEPJ5drD_rxWc759WmZscQ=s0-d) |
Long-Term Stock Price Chart Of Acme United (ACU) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sIVBRGC9qLw5DUu7N2FMkIQ8Z1SBJsXe6wPgpUsRkYHTtE0wkhJqHA6LLYUWTEmxsv8SRdwEEzH7iqJEcdLCvnPCHqcmSrSLymrwr4P5ZIrKcFDtQ8rJGOdq790m1mVMjH9YHKPRtTuEDLBAeM19vhdo5HUZ5Adfj5pLoZpDtkKWSMxfMUGZNYxmDK7O_GaF7a8aieB9ORjUUizNDCFPFy10XlOrynnq_Lsm6Bkqrj17EPFRo98OmUWsLd6aq7ONa528_entYgVRjhgrNFT-T4Aqnti3r9Z8IlZ1xjbdDEUzrX00vq7k7dI8PdFmQGYtfuS_1h9FprbZ65EPhV1Q=s0-d) |
Long-Term Dividend Payment History of Acme United (ACU) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3qb7fCv-phHevvY60eB3KDcTxD9ir8KPc0iaFJJgrJ831jgVFkiqLGlj1dyyUWslCLwzkAtcWQHr4vsolGhzoo7lUh8jVRb7CxAU5OxhnZI4d9dRu4l92U27PuFUTkd-Mfxiq0Uki-M9IHPI7oNNMBNotMPb8kiP68ECIU_7if2x-U8ZlbOyaXGAqj7hM6zhbS4IAENyObN1d5tTzOixiGLDpFWUGveFIRxh6T8ikPV2sppNQ64RzmsSy07YcSRw6Rhu-5c7xlTRNfRZ76hY5uDwiK5gNBT6EDsgsOPqoIngHn7oNsup2RSTvFR8GxDrkagEnCv9GIvJ5q93ij8AA0_h2KJbc78H_EpxOqXFi7P8J1G6yuyhNoAHutvwvIFanoL09VIsFRvLjJkisSDk7onUOTdf8HrNcOoOmjWcDqo_qS3t6BM2Z375-tBCD7lK_oS3IgILXhkLbujslI8OwrCxp-AGr5H2Krlwa_KRzWwstXyojtzMGa7gTXa8VTypEb0KRnKMB1UnK2nIF=s0-d) |
Long-Term Dividend Yield History of Acme United (ACU) |
Raven Industries (NASDAQ:RAVN) has a market capitalization of $1.14 billion. The company employs 1,286 people, generates revenue of $394.68 million and has a net income of $42.90 million. Raven Industries’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $78.19 million. The EBITDA margin is 19.81 percent (the operating margin is 16.21 percent and the net profit margin 10.87 percent).
Financial Analysis: The total debt represents 0.00 percent of Raven Industries’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 18.15 percent was realized by Raven Industries. Twelve trailing months earnings per share reached a value of $1.09. Last fiscal year, Raven Industries paid $0.48 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 28.74, the P/S ratio is 2.89 and the P/B ratio is finally 4.53. The dividend yield amounts to 1.53 percent and the beta ratio has a value of 0.75.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vObSDVvEiJjQqhavT-K0AL7LPnhkRp8Fo8d1Owk13ZzguSW9L4LUE_wEtXpn_SlDQvMbHN_tEL7Qhh7nsjyS0NOrvJpkGQvNRi_Q9WhZa_Yzo-J8Nk_ekZO4_y8u0xnOnf4kVim1IqEtU9hz0a-Cp6fk6Dx4otELKj=s0-d) |
Long-Term Stock Price Chart Of Raven Industries (RAVN) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_s8VZ7yI7Ick9B9-57rJv12vP2ZFDYZl9KKU638Lzh0fjcf-zHUXykry6fGx1K4Y7MgyaDB6emeYWiQJ9HPZdZR3XIt-JIBFVfN0oxHStDNBx1vZ1IfDczNQV8i5tFAJMf73wuSa4wovnhtXtGNmc-koecsWbjavdCo20NFzcKsSZ9fuAMjGOCk2ZrT4-2HkWeaR63ShwLd8fgeUZL6Bmk_SrW4M9fLas-acS03GgSgRU74uxCDXE3bg5pCioVkTLlevyLiqWuVEU3njZ-NFophX8pNAZqBVnq5WGJIM1yIZS2FmejSMObW8zn8rx4YtcmnIDN3N9yArIxIh0dT4iM=s0-d) |
Long-Term Dividend Payment History of Raven Industries (RAVN) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tw5_kAaYGdYe8YXJ66KWlfxbnUwApLyaYRnQPEtBYeB69D70p5b9FMJMIC6ygDXkp5JcrOpy-iZkDXTrn9_dskc0s6bCkID_TPb1yP0rBEOC1FC4aqkv1KOGoeaPtJvNR2ypjyDfhzn6-TzOJ0IN3iBZMnPvUMdGwTi3YlWhIKA2oYuKNzXu7fapfQxY7YdA4IWoki42DuNmlRBkiqhJNn8r2ZZvY_fEFqUT3JwYjLQmxwAyDqTjzN3iLgZvjqpXmbOcbKtw32F5yF9kDa2jQN5r-ZUkQbpoYLDu0bGPq1PO-_uMFx15oArlatxktCbfyLoZcGsTA3A67hrsLXN8NwnLspBCKcR3DVPoJRu44J4Qo7nSwui7qUA6xxpkCjjhjWAkhDoPMf0u_5XZDXbKSlMcsNnrB-jphKY3PGfUI4vbmF5hVvXx3cGCi3LMoBUvPdyRZMffJ7bVWVnBjdaFkDDdCmILkU9OCVurxPt-G9DSXDR333IVF9z3BtWyz72JWmHY2c7K5wdFdFdMoM9GLu=s0-d) |
Long-Term Dividend Yield History of Raven Industries (RAVN) |
J&J Snack Foods (NASDAQ:JJSF) has a market capitalization of $1.76 billion. The company employs 3,400 people, generates revenue of $867.68 million and has a net income of $64.38 million. J&J Snack Foods’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $131.46 million. The EBITDA margin is 15.15 percent (the operating margin is 11.23 percent and the net profit margin 7.42 percent).
Financial Analysis: The total debt represents 0.05 percent of J&J Snack Foods’s assets and the total debt in relation to the equity amounts to 0.07 percent. Due to the financial situation, a return on equity of 12.98 percent was realized by J&J Snack Foods. Twelve trailing months earnings per share reached a value of $3.58. Last fiscal year, J&J Snack Foods paid $0.61 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 26.37, the P/S ratio is 2.03 and the P/B ratio is finally 3.41. The dividend yield amounts to 1.36 percent and the beta ratio has a value of 0.55.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uYH8_iplhWxuRc_XwoPd3FSDxtTeu6U6Ay5N0jdw7qEwhBfXhUDWqSr9k347M5bkBD1j5QeSEzg4Px_TB6KwdPy0WhgInV1NhEEHWlhtWyFywigV3az0PYWNPnfBANvgE9O93nup_2cUL7tm732Ds6mtZT5iy14wNI=s0-d) |
Long-Term Stock Price Chart Of J&J Snack Foods (JJSF) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vmNfnmFIeify3QJQg4cgLMNy6TbVbrbTnNFVUNuQvYYXyOKrNrmpL7QF1m2zj0lJ9GXh_JaaSc14uhB0YFAk2E5EVzg75MVmj_BV9fH54IdUyaIG1RD-gnWBKNQG9CsKHE9RM2FxGPlyftV05kYGqTZ0EQMGpDtKdYhtgcycGPz2IDQqn9UZxxACellOq_KQJtFY4oI3nQ54tNKaEEA13A5i2rrhUON1H5qBQBXOwICSFYUkIsMm7GQEuowWZr9R28o6igPl-X85ibgxUdMaAfrsNy3MVCxKTp2JPUG6YBhmUkdYl5D0QS71eYc3Bj5Eziy2zhdir-4yIqH73k8Xul=s0-d) |
Long-Term Dividend Payment History of J&J Snack Foods (JJSF) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDda5g21PjkXjHD1K8rQiJduSMK1H7n1N0yqVEqb8ZN2nihWsfiEa7YcN1ySev55U292FA5PyJ1D6I_nNU9GYtp2QH9Ge3pkOD-P_K4asa6wS0dcGq6ZmypwcDwGYSA8BRPmBQA9zTSrGIg0vjBAUErsbgiHLGCnXHuRpp_FWmfkOy2bWJGEGsCvI45Bhr09CjMqLzHFwsFSCF0bG99CluUjDt_SkBO2xXOnoROVzAlYL4YALTBscSIBBDefKN08cDx5L5jephCn4q0lonLDyy_rHqdqHMyExaSoarSsnJVo1asOGLFjSp5HCGywnWBWjDsRTkw4LubVIx2yUomhgLybIgs_Bs6B8Hludwbr-4yHmhbbLWauCzIJyxSaN9xC587omBNngHQ-FfD9WsCZD41ATmzEDh2ny2z7rp8H9B_w-U965QSOXoOKfvEXXeKpmIU9AcdvrDVSXxtBNF6m7fG2S6CdYQZHiwAaoTt4xcKiKWdoSQWr8i9vY8mMMxEtoqGU4fIeFPnfN916vD2Ay4=s0-d) |
Long-Term Dividend Yield History of J&J Snack Foods (JJSF) |
Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $281.70 million. The company employs 273 people, generates revenue of $52.72 million and has a net income of $9.00 million. Mesa Laboratories’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15.63 million. The EBITDA margin is 29.64 percent (the operating margin is 22.35 percent and the net profit margin 17.07 percent).
Financial Analysis: The total debt represents 16.92 percent of Mesa Laboratories’s assets and the total debt in relation to the equity amounts to 25.65 percent. Due to the financial situation, a return on equity of 15.37 percent was realized by Mesa Laboratories. Twelve trailing months earnings per share reached a value of $2.48. Last fiscal year, Mesa Laboratories paid $0.58 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 32.37, the P/S ratio is 5.34 and the P/B ratio is finally 4.36. The dividend yield amounts to 0.75 percent and the beta ratio has a value of 0.53.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uJarcc6EFDKgDwi7nblHTOtjEg3xmlp25MHhIPyI-KOnrBvb7_XDVMSQkVKZs6KobxLJhd4rzhCHO99D0Q4h8i-qdaJsTkfk9JXCoPXFf7sZKUIlAKY3cZLYXlESzs_LQN5Pqi3Z5hEyJI6vuooFvDiZ82gnV9Nh3b=s0-d) |
Long-Term Stock Price Chart Of Mesa Laboratories (MLAB) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tWnIH2UDBDoiHjmcgovFNJO1GBl0Yci9Yd7R-XWEvrYEBmGqIRoJeYXOdQw4mNuXKPr_Y2SO8drVTqBBLk_hzVVkswAzWSuXjfwuIoTdYiTJ8cqXTXjsBZhs4xp_vAR-N80mBKVLQNLgjep--NqX_2YYIUuIbMR46DkQzMQ5TFlFOWSRxbw7pU7iQvPUoqFslwuE0SY8jaV1CUJFiyLMRtu56cx889rDrjr5iWA-HwAUuJ4yWNtmbEQn11LS9CMpsRTkP6mNb9i3pUnPo2vGSddRzlBR_9lOoJD4x7K3w8zSfnJYyiKhaUmMtDjxgUVHHU6Yf4nCmbTH_VwrukunI=s0-d) |
Long-Term Dividend Payment History of Mesa Laboratories (MLAB) |
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uunZuSxE8vu5wQRACfQyJtb8_CJi7BkVGfEiKI41z-3M2t0joADwPCP77rgkyJlL93MFpPfLDR9gfacQIzi8wKkINWz8UEdvVgDnZhAaI0RtMrKVQ4c2V47KRbIJqMhsqiV0bDTyoqLC0lFJvXca4Cm-Ju0ojolb-JK5mf-gtqsIgjHbOuJ1wE1upBCr0tJcQMh9sK4j1WGG9eRbLGlbGBFl-B3M5cfXx1FLgXpn9-4hhLZLnw6dQ8R29w7WsddxucGe6nlziNbRl1F_XGt01DZhZzArojsiEQdQokrCT8V7jNIRkjaU1WPYF5vHTDEsC8yTsYY5_8nwhDXOq-04z_Qm1YRDWoW3u_A61EJYlXz9ZMRKFUH9XFZ7nIiM207_7BY2XISZlJewwtkfWn4Vq-l00pGt054sghxET5fsULlWxf8x_DwvLRUjSxd_dezb7IYws1qSIP_9XiKIl8oMWgc2O9Zn3wxuDyPuYOEgnX2ytTQNleSmwKEwFbeDZVTw0Khq1kFyCTXXtgQ2UYEbY=s0-d) |
Long-Term Dividend Yield History of Mesa Laboratories (MLAB) |
------------------
*I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.
This article was written by Dividend Yield. If you enjoyed this article, please subscribe to his feed [RSS].